Related Articles

News
STAT+: Gilead defeats federal government in closely watched battle over patents for HIV prevention pills
May 9, 2023
San Francisco Biotechnology Network News
News, Syndication
Comments Off on STAT+: Gilead defeats federal government in closely watched battle over patents for HIV prevention pills
A U.S. court jury handed a major win to Gilead Sciences on Tuesday in a closely watched battle with the federal government over the rights to groundbreaking HIV prevention pills. […]

News
STAT+: Detailed data on Alzheimer’s therapy from Eisai, Biogen hold up to scientific scrutiny
November 30, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Detailed data on Alzheimer’s therapy from Eisai, Biogen hold up to scientific scrutiny
Lecanemab, a closely watched new treatment for Alzheimer’s from Eisai and Biogen, held up to scrutiny in a detailed scientific presentation Tuesday. […]

News
STAT+: Pharmalittle: Pfizer and Valneva delay application for Lyme vaccine; Moderna adjusts price for Covid-19 shot
May 5, 2023
San Francisco Biotechnology Network News
News, Syndication
Comments Off on STAT+: Pharmalittle: Pfizer and Valneva delay application for Lyme vaccine; Moderna adjusts price for Covid-19 shot
Moderna anticipates its updated Covid-19 vaccine will have a list price in a range of $110 to $130 per shot. […]